Authors: Sausville, EA Arbuck, SG Messmann, R Headlee, D Bauer, KS Lush, RM Murgo, A Figg, WD Lahusen, T Jaken, S Jing, XX Roberge, M Fuse, E Kuwabara, T Senderowicz, AM

Citation: Ea. Sausville et al., Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms, J CL ONCOL, 19(8), 2001, pp. 2319-2333